Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Phillips

Showing results (81-90 of 180) with videos related to

Pageof 18
Sort By:
Journal of the National Cancer Institute|May 28, 2021
Assessment of Ovarian Function in Phase III (Neo)Adjuvant Breast Cancer Clinical Trials: A Systematic EvaluationWanyuan Cui, Prudence A Francis, Sherene Loi, et al.
Familial Cancer|July 4, 2006
Screening behavior in women at increased familial risk for breast cancerYoland C Antill, John Reynolds, Mary Anne Young, et al.
Breast Cancer Research and Treatment|June 19, 2013
Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction modelGillian S Dite, Maryam Mahmoodi, Adrian Bickerstaffe, et al.
Australian Journal of Primary Health|February 24, 2015
Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?Kelly-Anne Phillips, Emma J Steel, Ian Collins, et al.
Plos One|October 25, 2011
Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381QSvetlana Pidasheva, Sara Trifari, Anne Phillips, et al.
Breast (Edinburgh, Scotland)|July 8, 2014
Assessing and managing breast cancer risk: clinicians' current practice and future needsIan M Collins, Emma Steel, G Bruce Mann, et al.
BMJ Open|June 18, 2025
Evaluation of a telehealth service to support breast cancer prevention medication uptake: a protocol of a mixed methods studyKatrina Louise West, Tim Spelman, Wanda Cui, et al.
The Lancet. Oncology|August 2, 2005
What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?Belinda Thewes, Bettina Meiser, Vlatka M Duric, et al.
Breast (Edinburgh, Scotland)|April 14, 2010
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trialKelly-Anne Phillips, Karin Ribi, Zhuoxin Sun, et al.
Breast Cancer Research and Treatment|November 4, 2010
Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trialKelly-Anne Phillips, Julie Aldridge, Karin Ribi, et al.
Pageof 18

Showing results (81-90 of 180) with videos related to

Sort By:
Pageof 18
Journal of the National Cancer Institute|May 28, 2021
Assessment of Ovarian Function in Phase III (Neo)Adjuvant Breast Cancer Clinical Trials: A Systematic EvaluationWanyuan Cui, Prudence A Francis, Sherene Loi, et al.
Familial Cancer|July 4, 2006
Screening behavior in women at increased familial risk for breast cancerYoland C Antill, John Reynolds, Mary Anne Young, et al.
Breast Cancer Research and Treatment|June 19, 2013
Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction modelGillian S Dite, Maryam Mahmoodi, Adrian Bickerstaffe, et al.
Australian Journal of Primary Health|February 24, 2015
Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?Kelly-Anne Phillips, Emma J Steel, Ian Collins, et al.
Plos One|October 25, 2011
Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381QSvetlana Pidasheva, Sara Trifari, Anne Phillips, et al.
Breast (Edinburgh, Scotland)|July 8, 2014
Assessing and managing breast cancer risk: clinicians' current practice and future needsIan M Collins, Emma Steel, G Bruce Mann, et al.
BMJ Open|June 18, 2025
Evaluation of a telehealth service to support breast cancer prevention medication uptake: a protocol of a mixed methods studyKatrina Louise West, Tim Spelman, Wanda Cui, et al.
The Lancet. Oncology|August 2, 2005
What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?Belinda Thewes, Bettina Meiser, Vlatka M Duric, et al.
Breast (Edinburgh, Scotland)|April 14, 2010
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trialKelly-Anne Phillips, Karin Ribi, Zhuoxin Sun, et al.
Breast Cancer Research and Treatment|November 4, 2010
Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trialKelly-Anne Phillips, Julie Aldridge, Karin Ribi, et al.
Pageof 18